{"id":5520,"date":"2006-10-17T11:08:00","date_gmt":"2006-10-17T11:08:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=5520"},"modified":"2026-04-02T09:09:10","modified_gmt":"2026-04-02T09:09:10","slug":"planuri-locale","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=5520","title":{"rendered":"Planuri locale"},"content":{"rendered":"<p><P class=text style=\"MARGIN: 0cm 0cm 0pt\" align=justify>In <?xml:namespace prefix = st1 ns = \"urn:schemas-microsoft-com:office:smarttags\" \/><st1:country-region w:st=\"on\"><st1:place w:st=\"on\">Romania<\/st1:place><\/st1:country-region>, Ranbaxy va produce, va dezvolta noi produse, va lansa medicamente destinate pietelor Uniunii Europene si Comunitatii Statelor Independente (CSI).<\/P><?xml:namespace prefix = o ns = \"urn:schemas-microsoft-com:office:office\" \/><o:p><SPAN class=text>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify><o:p>&nbsp;<\/o:p><\/P>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify><STRONG>ACHIZITII<\/STRONG>: Malvinder Singh spune ca, pentru moment, Ranbaxy nu negociaza o preluare pe piata romaneasca, desi este in continuare interesata de alte achizitii.<\/P>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify>&nbsp;<\/P>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify><STRONG>LANSARI<\/STRONG>: Potrivit planurilor in derulare, in urmatoarele 15 luni vor fi lansate pe piata romaneasca 40 de noi produse.<\/P>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify>&nbsp;<\/P>  <P class=MsoNormal style=\"MARGIN: 0cm 0cm 0pt\" align=justify><STRONG>CERCETARE<\/STRONG>: Ranbaxy pune accentul puternic pe activitatea de cercetare si dezvoltare, iar platforma din <st1:country-region w:st=\"on\"><st1:place w:st=\"on\">Romania<\/st1:place><\/st1:country-region> pare foarte potrivita pentru acest tip de activitati. Potrivit lui Singh, 6-7% din veniturile companiei sunt cheltuite pentru R&#038;D.<\/P><\/SPAN><\/o:p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In Romania, Ranbaxy va produce, va dezvolta noi produse, va lansa medicamente destinate pietelor Uniunii Europene si Comunitatii Statelor Independente (CSI). &nbsp; ACHIZITII: Malvinder Singh spune ca, pentru moment, Ranbaxy nu negociaza o preluare pe piata romaneasca, desi este in continuare interesata de alte achizitii. &nbsp; LANSARI: Potrivit planurilor in derulare, in urmatoarele 15 luni [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[4793],"class_list":["post-5520","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-planuri-locale"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/5520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5520"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/5520\/revisions"}],"predecessor-version":[{"id":26890,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/5520\/revisions\/26890"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}